PR > Press Releases

본문바로가기

KOR ENG

sitemap

PR

SK bioscience company news updates

Press releases

SK bioscience and CEPI Expand Partnership to Develop Vaccine Candidate against COVID-19 Variants

2021 .03 .11
SK Bioscience - Novavax-KDCA Sign Licensing Agreement and Purchase Agreement for Novavax´ COVID-19 Vaccine Candidate

2021 .02 .16
SK bioscience Submits Securities Report Aiming for KOSPI Listing by March

2021. 02. 08
SK bioscience Collaborates with GSK on COVID-19 Vaccine Development

2021. 02. 05
SK bioscience Signs Joint Sales Contract of Five Major Vaccines with GSK

2021. 01. 06
SK bioscience’s Typhoid Conjugate Vaccine Candidate Demonstrates Successful Phase III Clinical Trial Results

2020. 12. 17
SK bioscience’s COVID-19 Vaccine Candidate Is Chosen to First ‘Wave2’ Supporting Candidate

2020. 12. 10
SK bioscience-Seoul National University Hospital Agree Clinical Trial Cooperation for COVID-19 Vaccine ‘NBP2001’

2020. 12. 02
SK bioscience Announces Filing for KOSPI IPO

2020. 11. 30
SK bioscience’s COVID-19 Vaccine Candidate Enters Clinical Trial

2020. 11. 25